PR Newswire Leap Therapeutics Reports Second Quarter 2024 Financial Results Leap Therapeutics Reports Second Quarter 2024 Financial Results PR Newswire CAMBRIDGE, Mass., Aug. 12, 2024 CAMBRIDGE, Mass., Aug. 12...\n more…
PR Newswire Leap Therapeutics Reports First Quarter 2024 Financial Results Leap Therapeutics Reports First Quarter 2024 Financial Results PR Newswire CAMBRIDGE, Mass., May 13, 2024 CAMBRIDGE, Mass., May 13, 2024...\n more…
PR Newswire Leap Therapeutics Announces $40 Million Private Placement Leap Therapeutics Announces $40 Million Private Placement PR Newswire CAMBRIDGE, Mass., April 11, 2024 Net proceeds, along with existing...\n more…
PR Newswire Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire CAMBRIDGE, Mass., March 18...\n more…
PR Newswire Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe...\n more…
PR Newswire Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire CAMBRIDGE...\n more…